Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
Advanced NanoTherapies (ANT) develops next-generation drug-coated balloons (DCBs) using nanotechnology to treat vascular disease. The company operates in the medical device and nanomedicine field, focused on cardiovascular and endovascular interventions.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
AecorBio is an IND-stage biopharmaceutical company that has built a high-throughput peptide drug discovery platform targeting drug-resistance mechanisms in oncology, immunology, and neurology. Its lead candidate, FT-002a, is an orally available peptide co-therapeutic aimed at restoring androgen receptor inhibitor sensitivity in castration-resistant prostate cancer.
0 investors
0 investors
AEMS Corp solves viscosity problems in liquid formulations using proprietary and patented methods and an automated high-throughput, microscale lab, focusing primarily on next-generation pharmaceuticals such as high-concentration injectable biologics and siRNA therapeutics. It also formulates antimicrobial and edible sprayable coatings and other molecular systems for companies whose product development is blocked by viscosity challenges.
0 investors
0 investors
0 investors
Aether Therapeutics is a clinical-stage biotech company developing ATX-1209 (oral 6Ξ²-naltrexol), a first-in-class Β΅-opioid receptor modulator designed to reduce opioid-induced physical dependence without affecting pain relief or triggering withdrawal. Its pipeline targets chronic opioid pain dependence, opioid use disorder, neonatal opioid withdrawal syndrome, and acute/cancer pain.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
AffinityBio develops LifeScale, a diagnostic system that uses population-profiling technology to identify Gram-negative bacteria in positive blood cultures and perform antibiotic susceptibility testing in roughly 4.5 hours. The system automates sample inoculation, incubation, reading, and reporting for clinical microbiology labs.
0 investors
AGAE Technologies manufactures and supplies natural rhamnolipid biosurfactants at large scale, produced via proprietary fermentation and purification, as an alternative to petroleum-based surfactants. It serves global R&D labs and commercial partners across personal care, home care, pharmaceuticals, agriculture, and environmental remediation, and sells rhamnolipid-based skincare and home products under its MayLΕ« brand.
0 investors